S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
The only accurate crypto trading system I know … (Ad)
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
This Apple-like Innovator is Revolutionizing Healthcare (Ad)
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Biden replacement revealed? (Ad)
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
The only accurate crypto trading system I know … (Ad)
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
This Apple-like Innovator is Revolutionizing Healthcare (Ad)
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Biden replacement revealed? (Ad)
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
The only accurate crypto trading system I know … (Ad)
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
This Apple-like Innovator is Revolutionizing Healthcare (Ad)
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Biden replacement revealed? (Ad)
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
The only accurate crypto trading system I know … (Ad)
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
This Apple-like Innovator is Revolutionizing Healthcare (Ad)
The Charles Schwab Company Can Hit New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Biden replacement revealed? (Ad)
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
Free Trial
NYSE:BIO.B

Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)
Free BIO.B Stock Alerts
$338.55
0.00 (0.00%)
(As of 04/15/2024 ET)
Compare
Today's Range
$338.55
▼
$338.55
50-Day Range
$306.70
▼
$352.91
52-Week Range
$271.00
▼
$467.95
Volume
242 shs
Average Volume
54 shs
Market Capitalization
$9.66 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media
BIO.B stock logo

About Bio-Rad Laboratories Stock (NYSE:BIO.B)

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

BIO.B Stock Price History

BIO.B Stock News Headlines

April 10, 2024 | businesswire.com
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
April 1, 2024 | finance.yahoo.com
Unlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care Solutions
April 16, 2024 | Gold Safe Exchange (Ad)
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
April 1, 2024 | uk.finance.yahoo.com
Global Glucometer Market Projected to Reach $30.5 Billion by 2030, With a CAGR of 8.9%
March 26, 2024 | msn.com
Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration
March 17, 2024 | finance.yahoo.com
BIO Apr 2024 350.000 put
March 16, 2024 | finance.yahoo.com
BIO Apr 2024 330.000 call
March 14, 2024 | finanznachrichten.de
InsightAce Analytics Pvt. Ltd.: Combo IVD Market worth $920.9 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
April 16, 2024 | Gold Safe Exchange (Ad)
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
February 27, 2024 | msn.com
Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production
February 14, 2024 | markets.businessinsider.com
Bio-Rad Laboratories is about to announce earnings — here's what Wall Street expects
February 6, 2024 | finance.yahoo.com
Recombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets™.
February 5, 2024 | nz.finance.yahoo.com
Meta's fake videos should be labelled, says board
January 27, 2024 | markets.businessinsider.com
RBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)
December 10, 2023 | businesswire.com
Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of ...
November 14, 2023 | msn.com
Bio-Rad (BIO) Hurt by Macroeconomic Woes, Margin Pressure
October 26, 2023 | finance.yahoo.com
Bio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss Estimates
October 26, 2023 | reuters.com
Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending
September 13, 2023 | thestreet.com
Bio-Rad Laboratories Inc. Class B
July 26, 2023 | technews.tmcnet.com
Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement
June 16, 2023 | msn.com
Bio-Rad Laboratories (BIO) Dips More Than Broader Markets: What You Should Know
June 16, 2023 | markets.businessinsider.com
The Latest Analyst Ratings for Bio-Rad Laboratories
June 9, 2023 | msn.com
Bio-Rad Laboratories (BIO) Outpaces Stock Market Gains: What You Should Know
May 24, 2023 | msn.com
Death Cross Looms Over Bio-Rad Laboratories Investors
May 5, 2023 | msn.com
Credit Suisse Maintains Bio-Rad Laboratories Inc. - (BIO) Outperform Recommendation
May 5, 2023 | msn.com
Bio-Rad’s stock leads the S&P 500 decliners, as they suffer the biggest selloff in 36 years after disappointing results.
April 27, 2023 | msn.com
Bio-Rad Laboratories (BIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
See More Headlines
Receive BIO.B Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/15/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NYSE:BIO.B
CUSIP
N/A
CIK
12208
Web
www.bio-rad.com
Phone
510-724-7000
Fax
1-510-7415815
Employees
7,900
Year Founded
1952

Profitability

EPS (Most Recent Fiscal Year)
($21.49)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-637,320,000.00
Net Margins
-23.86%
Pretax Margin
-31.82%
Return on Equity
3.90%
Return on Assets
2.77%

Debt

Debt-to-Equity Ratio
0.14
Current Ratio
5.83
Quick Ratio
4.34

Sales & Book Value

Annual Sales
$2.67 billion
Price / Sales
3.61
Cash Flow
$12.10 per share
Price / Cash Flow
27.97
Book Value
$306.51 per share
Price / Book
1.10

Miscellaneous

Outstanding Shares
28,520,000
Free Float
20,425,000
Market Cap
$9.66 billion
Optionable
Not Optionable
Beta
0.66

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Norman D. Schwartz (Age 72)
    Chairman, CEO & Pres
    Comp: $3.15M
  • Mr. Ilan Daskal (Age 56)
    Exec. VP & CFO
    Comp: $1.18M
  • Dr. Andrew J. Last Ph.D. (Age 62)
    Exec. VP & COO
    Comp: $1.54M
  • Mr. Michael Crowley (Age 60)
    Exec. VP of Global Commercial Operations
    Comp: $974.94k
  • Ms. Dara Grantham Wright (Age 46)
    Exec. VP & Pres of Clinical Diagnostics Group
    Comp: $1.06M
  • Mr. Ajit Ramalingam (Age 49)
    Sr. VP & Chief Accounting Officer
  • Mr. Yong Chung
    VP of Investor Relations
  • Mr. Timothy S. Ernst (Age 62)
    Exec. VP, Gen. Counsel & Sec.
  • Colleen Corey
    Sr. VP of Global HR
  • Lee Boyd
    Sr. VP of Global Commercial Operations - Asia Pacific

Key Competitors

View All Competitors

BIO.B Stock Analysis - Frequently Asked Questions

How have BIO.B shares performed in 2024?

Bio-Rad Laboratories' stock was trading at $320.65 at the beginning of 2024. Since then, BIO.B shares have increased by 5.6% and is now trading at $338.55.
View the best growth stocks for 2024 here.

When is Bio-Rad Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our BIO.B earnings forecast.

How were Bio-Rad Laboratories' earnings last quarter?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) released its quarterly earnings results on Thursday, February, 15th. The company reported $3.10 EPS for the quarter. The company earned $681.18 million during the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive trailing twelve-month return on equity of 3.90%.

How do I buy shares of Bio-Rad Laboratories?

Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Bio-Rad Laboratories have any subsidiaries?
The following companies are subsidiares of Bio-Rad Laboratories: BIO-RAD spol. s r.o., Bio-Metrics (U.K.) Limited, Bio-Metrics Limited, Bio-Metrics Properties Limited, Bio-Rad (France), Bio-Rad (Shanghai) Life Science Research & Development Co. Ltd., Bio-Rad 1, Bio-Rad AbD Serotec GmbH, Bio-Rad AbD Serotec Ltd, Bio-Rad China Ltd., Bio-Rad Denmark ApS, Bio-Rad Europe GmbH, Bio-Rad Export LLC, Bio-Rad France, Bio-Rad France Holding, Bio-Rad Germany Holding GmbH, Bio-Rad Haifa Ltd., Bio-Rad Holdings LLC, Bio-Rad Hungary Trading LLC, Bio-Rad IHC Europe GmbH, Bio-Rad Innovations, Bio-Rad Korea Ltd., Bio-Rad Laboratories (Canada) Limited, Bio-Rad Laboratories (India) Private Limited, Bio-Rad Laboratories (Israel) Inc., Bio-Rad Laboratories (Pty) Ltd, Bio-Rad Laboratories (Shanghai) Co. Ltd., Bio-Rad Laboratories (Singapore) Pte Ltd, Bio-Rad Laboratories AB, Bio-Rad Laboratories AG, Bio-Rad Laboratories B.V., Bio-Rad Laboratories Ges.m.b.H., Bio-Rad Laboratories GmbH, Bio-Rad Laboratories K.K., Bio-Rad Laboratories Limited, Bio-Rad Laboratories Logistik GmbH, Bio-Rad Laboratories Ltd., Bio-Rad Laboratories M.EPE, Bio-Rad Laboratories NV, Bio-Rad Laboratories Pty Ltd, Bio-Rad Laboratories S.A., Bio-Rad Laboratories S.r.l., Bio-Rad Laboratories SAS, Bio-Rad Laboratories-Aparelhos e Reagentes para Laboratórios Lda, Bio-Rad Laboratorii OOO, Bio-Rad Laboratórios Brasil Ltda., Bio-Rad Luxembourg S.à r.l., Bio-Rad Medical Diagnostics GmbH, Bio-Rad Middle East FZ-LLC, Bio-Rad Norway AS, Bio-Rad Pacific Limited, Bio-Rad Polska Sp. z o.o., Bio-Rad QL Inc., Bio-Rad S.A., Bio-Rad Services France, Bio-Rad Services UK Limited, Blackhawk Biosystems, Bridger Technologies Inc., Celsee, DiaMed (G.B.) Ltd, DiaMed (Schweiz) GmbH, DiaMed Benelux NV, DiaMed Diagnostika Deutschland GmbH, DiaMed Fennica Oy, DiaMed France SA, DiaMed GmbH, DiaMed Holding AG, DiaMed Holding GmbH, DiaMed Latino-América S.A., DiaMed S.E.A. Limited, DiaMed Österreich GmbH, Distribudora de Analítica para la Medicina Ibérica S.A.U., GnuBIO Inc., IMV Medical Information Division Inc., International Marketing Ventures Ltd., MJ GeneWorks, QuantaLife, Raindance Technologies Limited, Raindance Techologies Inc., Research Specialties for Laboratories NV, Respiratory Diagnostics Inc., and Wuxi BioCanal Nano Technology Co. Ltd..
Read More
This page (NYSE:BIO.B) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The Greatest Bull Market in Crypto History…
Weiss Ratings